Citation only
via OpenAlex
Conditional control of human wildtype and mutated [A30P] alpha-synuclein in a mouse model of Parkinson's disease
Silke Nuber, T Schmidt, Hans‐Werner Habbes, Marlen Löbbecke‐Schumacher, Peter Teismann, Jörg Bernhard Schulz, Bernd Jürgen Pichler, Manuela Neumann, Markus Fendt, Daniela Berg, Carsten Holzmann, Ute Grasshoff, Jana Boy, Ina Schmitt, A. Bornemann
Aktuelle Neurologie · 2005
Abstract
Alpha-synuclein, a small soluble protein is expressed primarily at presynaptic terminals in the central nervous system. It has been implicated in the pathophysiology of many neurodegenerative disorders, including Parkinson's disease and dementia with Lewy-bodies, collectively referred to as synucleinopathies. As neurodegenerative disorders like Parkinson's disease are charecterized by progressive neuropathological and clinical symptoms, conditional models of these neurodegenerative diseases are powerful means to analyze the relationship between transgene expression and progression of the disease. We have created a conditional mouse model of synucleinopathies by using the tet-off gene system combined with expression of human wildtype or mutated (A30P) alpha-synuclein. We investigated the behavioral and neuropathological effects of overexpression of human alpha-synuclein under conditional control of both the PrP promotor and the CaMKIIalpha promotor. Western blot analyses revealed that double-transgenic mice express alpha-synuclein at different levels in specific brain regions. The expression-pattern and level of human alpha-synuclein in the brain of double-transgenic mice depend on both the neuron-specific promotor and the integration site of the human alpha-synuclein construct. Histological analysis of the brainsof transgenic mice showed aberrant expression of the protein in cell soma, axons and synapses, but no Lewy body-like alpha-synuclein inclusions could be identified, yet. We currently investigate, whether focal neurodegeneration, which we observed in one 9 month-old CaMKIIalpha-h[wt]alpha-synuclein double-transgenic mouse could be reproduced. Double-transgenic males of this line performerd significantly weaker on accelerated rotarod than age-matched control animals. HPLC-analyses of double-transgenic mice that showed expression of the transgene limited to the olfactory bulb, demonstrate significantly lower levels of Dopamin, DOPAC and HVA in this brain region. In all lines administration of doxycycline downregulates alpha-synuclein expression to basal level. Our conditional mouse-model may help to define the role of human alpha-synuclein in synucleinopathies and might be used to demonstrate whether neuropathological symptoms of these diseases are reversible.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1055/s-2005-919318
- Canonical
- link ↗
- Fetched
- 2026-10-21 MST
Cite this
APA
Nuber, S., Schmidt, T., Habbes, H., Löbbecke‐Schumacher, M., Teismann, P., Schulz, J.B., Pichler, B.J., Neumann, M., Fendt, M., Berg, D., Holzmann, C., Grasshoff, U., Boy, J., Schmitt, I., Bornemann, A., Zimmermann, F., Kuhn, W., Prusiner, S.B., Petrasch‐Parwez, E., & Riess, O. (2005). Conditional control of human wildtype and mutated [A30P] alpha-synuclein in a mouse model of Parkinson's disease. <em>Aktuelle Neurologie</em>. https://doi.org/10.1055/s-2005-919318
Vancouver
Nuber S, Schmidt T, Habbes H, Löbbecke‐Schumacher M, Teismann P, Schulz JB, et al. Conditional control of human wildtype and mutated [A30P] alpha-synuclein in a mouse model of Parkinson's disease. Aktuelle Neurologie. 2005. doi:10.1055/s-2005-919318.
BibTeX
@article{silke2005Condit,
title = {Conditional control of human wildtype and mutated [A30P] alpha-synuclein in a mouse model of Parkinson's disease},
author = {Silke Nuber and T Schmidt and Hans‐Werner Habbes and Marlen Löbbecke‐Schumacher and Peter Teismann and Jörg Bernhard Schulz and Bernd Jürgen Pichler and Manuela Neumann and Markus Fendt and Daniela Berg and Carsten Holzmann and Ute Grasshoff and Jana Boy and Ina Schmitt and A. Bornemann and F Zimmermann and Wilfried Kuhn and Stanley B. Prusiner and Elisabeth Petrasch‐Parwez and O Riess},
journal = {Aktuelle Neurologie},
year = {2005},
doi = {10.1055/s-2005-919318},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
The EMBO Journal 2026
Open access · CC-BY
SenFlag gene signature identifies senescent cells in mouse and human tissues through a conserved core transcriptional program
IUBMB Life 2004
Citation only
Microarray Analysis in Alzheimer's Disease and Normal Aging
Experimental gerontology 2026
Citation only
In silico analysis of transcriptomic datasets reveals nonlinear gene expression trajectories in aging microglia and Alzheimer's disease.
Journal of Visualized Experiments 2008
Open access · OA
Application of a C. elegans Dopamine Neuron Degeneration Assay for the Validation of Potential Parkinson's Disease Genes
PLoS ONE 2019
Open access · CC-BY
Novel role of extracellular matrix protein 1 (ECM1) in cardiac aging and myocardial infarction
biorxiv 2024
Preprint · CC-BY